NEWS
Kossel and InnoMed Enter Strategic Partnership for Global Commercialization of Python DCB
Exclusive overseas distribution plus technical cooperation advances Kossel’s peripheral DCB value chain roadmap Suzhou, China — Kossel Medtech (Suzhou) Co., Ltd. (“Kossel”) has entered into a
Key Milestone: Kossel’s Overseas Peripheral Portfolio Accelerates Global Expansion via EU CE‑MDR Certification
Kossel is pleased to announce a major regulatory milestone. Its peripheral interventional device portfolio has obtained EU CE‑MDR certification, granting official European market access and
SOLACI & SBHCI 2026 Concludes Successfully; Kossel Expands Partnership Footprint Across South America
Held in São Paulo, Brazil from July 29 to 31, 2026, SOLACI & SBHCI 2026 stands as the flagship annual event for cardiovascular intervention across
Kossel Makes a Stunning Debut on the Global Medical Stage — A Successful Wrap-up of CVIT 2026!
From July 16 to 18, 2026, the 34th Annual Meeting of the Japanese Cardiovascular Intervention Therapeutics (CVIT 2026) was successfully held at Tokyo International Forum.
Good News | Selepump® Inflation Device Receives PMDA Approval in Japan
Following its successful registration with Singapore’s Health Sciences Authority (HSA), Kossel Medtech’s Selepump® Inflation Device has now obtained approval from Japan’s Pharmaceuticals and Medical Devices
Good News | Selepump® Inflation Device Receives HSA Approval in Singapore
Recently, Selepump® Inflation Device, developed by Kossel Medtech (Suzhou) Co., Ltd., has successfully obtained market approval from the Singapore Health Sciences Authority (HSA), officially gaining